D. E. Shaw & Co., Inc. Staar Surgical CO Put Options Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$50.45 - $72.82 $2.41 Million - $3.47 Million	-47,700 Reduced 61.0%	30,500 $1.6 Million
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $3.66 Million - $5.96 Million	78,200 New	78,200 $3.8 Million
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $2.5 Million - $4.04 Million	-43,200 Reduced 75.13%	14,300 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $162.68 $1.89 Million - $2.51 Million	15,400 Added 36.58%	57,500 $7.39 Million
Q2 2021 Aug 16, 2021	BUY	$105.76 - $154.96 $1.06 Million - $1.55 Million	10,000 Added 31.15%	42,100 $6.42 Million
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $1.17 Million - $1.88 Million	14,900 Added 86.63%	32,100 $3.38 Million
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $497,252 - $860,000	17,200 New	17,200 $549,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.